← Browse by Condition
Medical Condition
dlbcl
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 2, Phase 3
NCT06569485 Phase 2
Recruiting
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients
Enrollment
38 pts
Location
China
Sponsor
Sun Yat-sen University
NCT05139017 Phase 2, Phase 3
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Enrollment
290 pts
Location
United States, Argen...
Sponsor
Merck Sharp & Dohme LLC